Table 1.

Patient’s characteristics.

Total Number of Patients	n = 335
age at PSMA-PET/CT (years), median (range)	67 (38–84)
WHO grading, n = 326
1	36 (10.7%)
2	85 (25.4%)
3	57 (17.0%)
4	58 (17.3%)
5	90 (26.9%)
PSA at initial diagnosis (ng/mL), median (range), n = 331	11 (1.2–511)
<10	153 (45.7%)
10–20	84 (25.1%)
>20	94 (28.1%)
risk classification according d’Amico, n = 335
low risk	15 (4.5%)
intermediate risk	101 (30.1%)
high risk	219 (65.4%)
PSMA-PET/CT tracer
68Ga-PSMA-11	272 (81.2%)
18F-PSMA-1007	63 (18.8%)
N staging according to PSMA-PET/CT, n = 335
cN0	254 (75.8%)
cN1	81 (24.2%)
M staging according to PSMA-PET/CT, n = 335
cM0	253 (75.5%)
cM1a	18 (5.4%)
cM1b	39 (11.6%)
cM1c	25(7.5%)